Top Industry News

The latest from small and Emerging Pharma companies featuring Newsoara, vTv Therapeutics, Angitia Biopharmaceuticals, Biomice, Lishan Biopharmaceuticals and Spruce Biosciences.  For news on the large and mid-sized bio/pharmaceutical companies, see Global…

AstraZeneca has announced a $15-billion investment in China through 2030 to expand medicines manufacturing and research and development (R&D).   China is AstraZeneca’s second-largest market and a strategic hub for global innovation,…

The latest from CDMOs, CMOs, and suppliers featuring Siegfried, Cellares, Alcami, Recipharm, Veranova, iOrganBio and Coating Place.   Chemicals/Chemical API Manufacturing * Siegfried to Acquire Drug-Substance Business of Noramco & Extracas Bioscience Biologics Manufacturing * Cellares Raises…

A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, and Halozyme. Highlights below.   For the latest news roundup on small and…

The latest from small and Emerging Pharma companies featuring Qilu, Eikon Therapeutics, Insilico, Eclipsebio, Terrain Bio, Elysium Therapeutics, and Fortitude Biosciences.  For news on the large and mid-sized bio/pharmaceutical companies, see…

Roche’s Genentech will more than double its initial investment in a biomanufacturing facility in Holly Springs, North Carolina, to approximately $2 billion, bolstering Roche’s and Genentech’s $50-billion investment in US manufacturing and R&D.   The expansion…

GSK has agreed to acquire RAPT Therapeutics, a South San Franciso, California-based, clinical-stage bio/pharmaceutical company, for $2.2 billion.   The acquisition includes ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal antibody, currently in Phase…

GSK and Shionogi & Co., an Osaka-based bio/pharmaceutical company, have reached an agreement with Pfizer for Pfizer to sell its 11.7% stake in ViiV Healthcare, a joint venture between GSK,…

The latest from CDMOs, CMOs, and suppliers featuring Apiject, Borealis Pharma, Sharp & Rentschler Biopharma.   Formulation Development/Drug Product Manufacturing * Apiject Signs Lease for Blow-Fill-Seal Facility Packaging * Borealis Pharma Investing $57 M in Polypropylene Mfg Facility * Sharp…

A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Bristol Myers Squibb, AstraZeneca, Pfizer, GSK, Novo Nordisk, and Daiichi Sankyo.  For the latest news roundup on small and Emerging Pharma companies,…